Latest Thrombophilia Stories
IMPACT Dx(TM) Combined Function System Will Also Be Available in the European Union SAN DIEGO, June 16, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience
A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.
Back in the mid 19th century, a French doctor, Armand Trousseau, discovered a connection between cancer and thrombosis â€“ the formation of often dangerous blood clots that can lead to venous occlusion.
Arming Healthcare Professionals to Stop the ClotÂ® TARRYTOWN, N.Y., Sept.
CHICAGO and HOBOKEN, N.J., Aug. 2 /PRNewswire/ -- Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center.
ROCKVILLE, Md., June 16 /PRNewswire-USNewswire/ -- According to a new report by HHS' Agency for Healthcare Research and Quality, there is insufficient evidence to conclude that genetic testing for two gene mutations in adults with a history of blood clots helps to prevent a condition known as deep-vein thrombosis or to improve other clinical outcomes. The report, a summary of which will be published in the June 17 issue of JAMA, also failed to find any benefit from genetic testing of family...
On-Demand Test for Genetic Risk of Thrombosis Improves Time-to-Result over Current Molecular Tests SUNNYVALE, Calif.
- Court Orders Confiscation of Diagnostica Stago's Inventory of Infringing Products - BEDFORD, Mass., May 4 /PRNewswire/ -- Instrumentation Laboratory Company and its parent company Instrumentation Laboratory S.p.A.
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) launched the Company's anticipated genetic controls business with the introduction of two new products at the Association for Molecular Pathology 2008 Annual Meeting.
By Poredos, P Jezovnik, M K During the last decade, the role of inflammation in the etiopathogenesis of arterial thrombosis has been elucidated. However, little is known about the relationship between inflammation and venous thrombosis.